{"id":174219,"title":"Notice of Intent Published in Canada Gazette Parts I and II, December 7, 2002 and Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T16:06:11.812000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/notice-intent-published-canada-gazette-parts-december-7-2002-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-topic.html","snippet":"Notice of Intent Published in Canada Gazette Parts I and II, December 7, 2002 and Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français…","rawSnapshotUrl":"/api/snapshots/raw/174219","browseUrl":"https://replay.healtharchive.ca/job-1/20250418160611/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/notice-intent-published-canada-gazette-parts-december-7-2002-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-topic.html#ha_snapshot=174219","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}